Not all PLCG2 mutations found causing BTKi resistance have yet been reported to also induce PLCγ2-associated antibody deficiency with immune dysregulation (APLAID), or without autoinflammation (PLAID), but many do. This evidence concerns the gene PLCG2 and agammaglobulinemia.